Trial intelligence / Profile preview

Levothyroxine liquid drops versus tablets for congenital hypothyroidism in children

2015-002462-24Phase 3Completed

Sponsor
Universal Pharmaceutical Industries UNIPHARMA
Start
Nov 2015
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, open-label trial of levothyroxine sodium in congenital hypothyroidism (CH) (2 arms), sponsored by Universal Pharmaceutical Industries UNIPHARMA. Started Nov 2015; status: completed.

02

Drugs

levothyroxine sodium
03

Conditions

congenital hypothyroidism (CH)

Beyond the preview

Go deeper on 2015-002462-24.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2015-002462-24.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call